EN | JPN | FR

Our Leadership Team

Zhifeng Liu

Director of Clinical Operations, China

Zhifeng Liu, serves as Director of Clinical Operation Lead of Ora China. Responsible for the oversight of China Clinical operation team as well as clinical studies on the operational part. Also help driving business in China. Zhifeng has more than 18 years of clinical operation and project management experience. He possesses a deep understanding of clinical study operation/team management and China’s regulatory environment. With a Master’s Degree in Clinical Pharmacology from Xiangya Medical School, Central South University, and a Bachelor’s Degree in Medical Science from Hunan Traditional Chinese Medicine University. Since September 2020, he has served as the Director of Clinical Operation Lead at Ora China, where he has successfully managed cross-functional teams to deliver high-quality clinical trials in compliance with all regulations and SOPs. His responsibilities have encompassed initiating, planning, executing, controlling, closing, and resourcing clinical trial projects, ensuring project timelines are maintained and the projects progress efficiently. Before joining Ora, Zhifeng held significant roles at TaiMei Medical Technology Ltd. as the Head of Clinical Operation, and at AstraZeneca as a Senior Project Manager, among others. His experience spans from building teams and business strategies from scratch to overseeing the execution of clinical studies, demonstrating leadership, accountability, and a results-oriented approach throughout his career.

We partner with industry-leading companies to create vision beyond what we see.

regeneron logo
alltergan logo
regentree logo
mallinkrodt logo
stealth logo
nicox logo
astellas logo
canon logo
rayner logo

For over 45+ years, Ora has been on the leading edge of ophthalmic product development.

When your product shows promise, let's prove it.

Ora LLC websites use cookies. By continuing to browse the site you are agreeing to our use of cookies.
For more details about cookies and their use, please see our Privacy Policy.